Discovery of new liver X receptor agonists by pharmacophore modeling and shape-based virtual screening

Journal of Chemical Information and Modeling

Volumn 54, Issue 2, 2014, Pages 367-371

  Temml, Veronika ^a   Voss, Constance V ^b   Dirsch, Verena M ^b   Schuster, Daniela ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ENGINEERING; CHEMISTRY;

CHOLESTEROL METABOLISM; LIPID LOWERING; LIPOGENESIS; LIVER X RECEPTORS; PHARMACOPHORE MODELING; SELECTIVE LIGANDS; SHAPE BASED; VIRTUAL SCREENING;

PHARMACODYNAMICS;

LIVER X RECEPTOR; ORPHAN NUCLEAR RECEPTOR;

CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER INTERFACE; CONFORMATION; DRUG POTENTIATION; DRUG SCREENING; LETTER; METHODOLOGY;

DRUG EVALUATION, PRECLINICAL; MODELS, MOLECULAR; MOLECULAR CONFORMATION; ORPHAN NUCLEAR RECEPTORS; USER-COMPUTER INTERFACE;

EID: 84894663300     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci400682b     Document Type: Article

References (28)

1. Ibanez, B.; Vilahur, G.; Cimmino, G.; Speidl, W. S.; Pinero, A.; Choi, B. G.; Zafar, M. U.; Santos-Gallego, C. G.; Krause, B.; Badimon, L.; Fuster, V.; Badimon, J. J. Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: Magnetic resonance imaging study in an experimental model of atherosclerosis J. Am. Coll. Cardiol. 2008, 51, 1104-1109
2. Nissen, S. E.; Tsunoda, T.; Tuzcu, E. M.; Schoenhagen, P.; Cooper, C. J.; Yasin, M.; Eaton, G. M.; Lauer, M. A.; Sheldon, W. S.; Grines, C. L.; Halpern, S.; Crowe, T.; Blankenship, J. C.; Kerensky, R. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: A randomized controlled trial JAMA, J. Am. Med. Assoc. 2003, 290, 2292-2300
3. Tardif, J.-C.; Grégoire, J.; L'Allier, P. L.; Ibrahim, R.; Lespérance, J.; Heinonen, T. M.; Kouz, S.; Berry, C.; Basser, R.; Lavoie, M.-A.; Guertin, M.-C.; Rodés-Cabau, J. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: A randomized controlled trial JAMA, J. Am. Med. Assoc. 2007, 297, 1675-1682
4. Cuchel, M.; Rader, D. J. Macrophage reverse cholesterol transport: Key to the regression of atherosclerosis? Circulation 2006, 113, 2548-2555
5. Tall, A. R. Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins J. Intern. Med. 2008, 263, 256-273
6. Santos-Gallego, C. G.; Ibanez, B.; Badimon, J. J. HDL-cholesterol: Is it really good? Differences between apoA-I and HDL Biochem. Pharmacol. 2008, 76, 443-452
7. Beaven, S. W.; Tontonoz, P. Nuclear receptors in lipid metabolism: Targeting the heart of dyslipidemia Annu. Rev. Med. 2006, 57, 313-329
8. Kalaany, N. Y.; Mangelsdorf, D. J. LXRs and FXR: The yin and yang of cholesterol and fat metabolism Annu. Rev. Med. 2006, 68, 159-191
9. Calkin, A. C.; Tontonoz, P. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR Nat. Rev. Mol. Cell. Biol. 2012, 13, 213-224
10. Jakobsson, T.; Treuter, E.; Gustafsson, J.-A.; Steffensen, K. R. Liver X receptor biology and pharmacology: new pathways, challenges and opportunities Trends Pharmacol. Sci. 2012, 33, 394-404
11. Joseph, S. B.; Castrillo, A.; Laffitte, B. A.; Mangelsdorf, D. J.; Tontonoz, P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors Nat. Med. 2003, 9, 213-219
12. Zelcer, N.; Tontonoz, P. Liver X receptors as integrators of metabolic and inflammatory signaling J. Clin. Invest. 2006, 116, 607-614
13. Tangirala, R. K.; Bischoff, E. D.; Joseph, S. B.; Wagner, B. L.; Walczak, R.; Laffitte, B. A.; Daige, C. L.; Thomas, D.; Heyman, R. A.; Mangelsdorf, D. J.; Wang, X.; Lusis, A. J.; Tontonoz, P.; Schulman, I. G. Identification of macrophage liver X receptors as inhibitors of atherosclerosis Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 11896-11901
14. Joseph, S. B.; McKilligin, E.; Pei, L.; Watson, M. A.; Collins, A. R.; Laffitte, B. A.; Chen, M.; Noh, G.; Goodman, J.; Hagger, G. N.; Tran, J.; Tippin, T. K.; Wang, X.; Lusis, A. J.; Hsueh, W. A.; Law, R. E.; Collins, J. L.; Willson, T. M.; Tontonoz, P. Synthetic LXR ligand inhibits the development of atherosclerosis in mice Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 7604-7609
15. Repa, J. J.; Liang, G.; Ou, J.; Bashmakov, Y.; Lobaccaro, J.-M. A.; Shimomura, I.; Shan, B.; Brown, M. S.; Goldstein, J. L.; Mangelsdorf, D. J. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRa and LXRb Genes Dev. 2000, 14, 2819-2830
16. Yoshikawa, T.; Shimano, H.; Amemiya-Kudo, M.; Yahagi, N.; Hasty, A. H.; Matsuzaka, T.; Okazaki, H.; Tamura, Y.; Iizuka, Y.; Ohashi, K.; Osuga, J.-I.; Harada, K.; Gotoda, T.; Kimura, S.; Ishibashi, S.; Yamada, N. Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter Moll. Cell. Biol. 2001, 21, 2991-3000
17. Lehrke, M.; Lebherz, C.; Millington, S. C.; Guan, H.-P.; Millar, J.; Rader, D. J.; Wilson, J. M.; Lazar, M. A. Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRa Cell Metab 2005, 1, 297-308
18. Bradley, M. N.; Hong, C.; Chen, M.; Joseph, S. B.; Wilpitz, D. C.; Wang, X.; Lusis, A. J.; Collins, A. R.; Hsueh, W. A.; Collins, J. L.; Tangirala, R. K.; Tontonoz, P. Ligand activation of LXRb reverses atherosclerosis and cellular cholesterol overload in mice lacking LXRa and apoE J. Clin. Invest. 2007, 117, 2337-2346
19. Molteni, V.; Li, X.; Nabakka, J.; Liang, F.; Wityak, J.; Koder, A.; Vargas, L.; Romeo, R.; Mitro, N.; Mak, P. A.; Seidel, H. M.; Haslam, J. A.; Chow, D.; Tuntland, T.; Spalding, T. A.; Brock, A.; Bradley, M. N.; Castrillo, A.; Tontonoz, P.; Saez, E. N-Acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRb J. Med. Chem. 2007, 50, 4255-4259
20. von Grafenstein, S.; Mihály-Bison, J.; Wolber, G.; Bochkov, V. N.; Liedl, K. R.; Schuster, D. Identification of novel liver X receptor activators by structure-based modeling J. Chem. Inf. Model. 2012, 52, 1391-1400
21. Discovery Studio,version 3.0; Accelrys: San Diego, CA; 2012. www.accelrys.com.
22. Berman, H. M.; Westbrook, J.; Feng, Z.; Gililand, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E. The protein data bank Nucleic Acids Res. 2000, 28, 235-242
23. ROCS, version 2.3.1.; OpenEye Scientific Software:SantaFe, NM, (2013. www.eyesopen.com.
24. Grant, J. A.; Gallardo, M. A.; Pickup, B. T. A fast method of molecular shape comparison: A simple application of a Gaussian description of molecular shape J. Comput. Chem. 1996) 17, 1653-1666
25. OMEGA, 2.2.1.; OpenEye Scientific Software Inc.:Santa Fe,NM, (2013, www.eyesopen.com.
26. Hawkins, P. C. D.; Skillman, A. G.; Warren, G. L.; Ellingson, B. A.; Stahl, M. T. Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database J. Chem. Inf. Model. 2010, 50, 572-584
27. Hawkins, P. C. D.; Nicholls, A. Conformer Generation with OMEGA: Learning from the Data Set and the Analysis of Failures J. Chem. Inf. Model. 2012, 52, 2919-2936
28. Specs compound library, 2012. www.specs.net.